Shree Ram Proteins to hold 17th AGM on March 5, 2026; to approve FY25 results & increase authorized capital
Shree Ram Proteins Limited will hold its 17th AGM on March 5, 2026, via VC/OAVM. Key agenda items include approving FY25 financial results, increasing authorized share capital to ₹125 crore, and appointing two new Independent Directors. The company will also seek approval for borrowing up to ₹500 crore and to dispose of assets.
The AGM includes proposals for significant corporate actions such as increasing authorized share capital, borrowing limits, and asset disposal, which can have a material impact on the company's future financial structure and operations.
The announcement is a routine notice for an Annual General Meeting and outlines standard corporate governance procedures and proposals. It does not contain information that suggests a significant positive or negative deviation from expected business operations.
Shree Ram Proteins Limited will convene its 17th Annual General Meeting (AGM) on Thursday, March 5, 2026, at 2:00 PM IST. The meeting will be conducted through Video Conference (VC) / Other Audio Visual Means (OAVM).
The AGM agenda includes the consideration and adoption of the Audited Financial Statements for the financial year ended March 31, 2025, along with the reports of the Board of Directors and Auditors. The shareholders will also vote on the re-appointment of Mr. Ravindra Kumar Singh as a Director retiring by rotation.
Key special businesses to be transacted include a proposal to increase the Company's authorized share capital from ₹50 crore to ₹125 crore. Additionally, the meeting will seek to regularize and appoint Ms. Naaz Jaiswal and Mr. Jayvir Vajubhai Kuvadiya as Independent Directors for a term of five years from their respective appointment dates in March 2025 and February 2026. The appointment of M/s. Payal Dhamecha & Associates as Secretarial Auditors for a term of five consecutive years (FY 2025-26 to FY 2029-30) will also be considered.
Furthermore, the shareholders will vote on ratifying the remuneration of the Cost Auditor, M/s. Tadhani & Co., for the financial year ending March 31, 2026. The board will also seek authority to borrow money, individually or collectively, in excess of the paid-up share capital and free reserves, up to an aggregate of ₹500 crore. Lastly, the board will seek authority to sell, dispose of, or create charges on the company's assets under Section 180(1)(a) of the Companies Act, 2013.
Remote e-voting will be available from Monday, March 2, 2026, at 10:00 AM, to Wednesday, March 4, 2026, at 5:00 PM. The record date for determining entitlement to receive the Annual Report and participate in the AGM is February 26, 2026.
What to do with a filing like this
Shree Ram Proteins Limited filed this with the NSE as a statutory disclosure, categorised under agm. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Shree Ram Proteins Limited. Read the original for the full detail.